NovoCure Ltd - Common Stock (NVCR)

Historical Holders from Q4 2015 to Q3 2025

Symbol
NVCR on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
111M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
91.7M
Holdings value
$1.19B
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
242
Number of buys
130
Number of sells
-122
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NovoCure Ltd - Common Stock (NVCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 8.6% +40% $125M $35.4M 9.64M +39.7% Soleus Capital Master Fund, L.P. 30 Sep 2025
BlackRock, Inc. 8.3% $169M 9.08M BlackRock, Inc. 31 Mar 2025
Capital World Investors 1.8% -65% $25.8M -$56.6M 2M -68.7% Capital World Investors 30 Sep 2025

Institutional Holders of NovoCure Ltd - Common Stock (NVCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 91.7M $1.19B -$65.9M $12.92 242
2025 Q2 94.5M $1.68B -$12.9M $17.80 238
2025 Q1 95.2M $1.7B +$20M $17.82 224
2024 Q4 91.6M $2.73B -$6.46M $29.80 236
2024 Q3 92.9M $1.45B -$11.2M $15.63 220
2024 Q2 92.9M $1.59B +$79.6M $17.13 229
2024 Q1 89.1M $1.39B -$17.8M $15.63 231
2023 Q4 90.5M $1.35B -$31.1M $14.93 213
2023 Q3 92.3M $1.49B -$68.4M $16.15 219
2023 Q2 90.4M $3.75B +$42.4M $41.50 255
2023 Q1 89.5M $5.38B +$285M $60.14 291
2022 Q4 84.8M $6.22B -$14.7M $73.35 292
2022 Q3 83.7M $6.36B +$227M $75.98 291
2022 Q2 80.4M $5.59B -$44.5M $69.50 291
2022 Q1 81.3M $6.73B +$217M $82.85 293
2021 Q4 79M $5.94B +$45.9M $75.08 292
2021 Q3 77.5M $9.01B -$79.4M $116.17 301
2021 Q2 77.6M $17.2B +$574M $221.82 351
2021 Q1 75.3M $9.95B +$138M $132.18 315
2020 Q4 74.2M $12.8B +$249M $173.04 348
2020 Q3 73.2M $8.15B +$548M $111.31 272
2020 Q2 69.1M $4.1B -$81.8M $59.30 257
2020 Q1 70.4M $4.74B +$74.8M $67.34 260
2019 Q4 69.2M $5.83B +$164M $84.27 256
2019 Q3 66.7M $4.99B +$90.6M $74.78 233
2019 Q2 65.9M $4.16B +$195M $63.23 190
2019 Q1 63.6M $3.06B +$301M $48.17 195
2018 Q4 57.3M $1.92B +$53.8M $33.48 162
2018 Q3 54.7M $2.87B +$204M $52.40 173
2018 Q2 51.8M $1.62B +$259M $31.30 159
2018 Q1 44M $959M +$149M $21.80 128
2017 Q4 37.4M $756M +$13.1M $20.20 124
2017 Q3 36.8M $731M +$98.8M $19.85 103
2017 Q2 31.9M $551M +$204M $17.30 83
2017 Q1 20.2M $164M +$27.1M $8.10 68
2016 Q4 20.3M $159M +$10.3M $7.85 73
2016 Q3 18.8M $161M -$21.8M $8.54 62
2016 Q2 19.4M $227M +$67.5M $11.67 65
2016 Q1 13.6M $197M +$32.4M $14.48 56
2015 Q4 11.3M $249M +$249M $22.36 47